FindTrial
Sign In

Study for the level of Circulating Sestrin2 in patients with type 2 diabetes and nephropathy

Study for the level of Circulating Sestrin2 in patients with type 2 diabetes and nephropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019561
Enrollment
Unknown
Registered
2018-11-18
Start date
2018-11-26
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Type 2 diabetic nephropathy stage I:?
type 2 diabetic nephropathy stage II:?
type 2 diabetic nephropathy stage III:?
type 2 diabetic nephropathy stage IV:?
type 2 diabetic nephropathy stage V:?
new type 2 diabetes group:?
????? :?

Sponsors

Affiliated Hospital of Weifang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes with nephropathy; 2. Aged 18-75 years old; 3. Understand the purpose of clinical trials and voluntarily participate in and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. acute complications of diabetes (including diabetic ketoacidosis, diabetic hyperosmolar state); 2. liver function impairment, cardiac insufficiency, etc.; 3. acute infection, tumor, pregnancy.

Design outcomes

Primary

MeasureTime frame
Sestrin2;—

Secondary

MeasureTime frame
HbA1c;BMI;BP;Urinary albumin/creatinine ratio;GFR;—

Countries

China

Contacts

Public ContactSun Xiaodong

Affiliated Hospital of Weifang Medical University

xiaodong.sun@wfmc.edu.cn+86 18653625906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026